SAN DIEGO and SUZHOU and SHANGHAI, China, July 31, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, today announced that the management team will participate in the BTIG Virtual Biotechnology Conference on August 7 – 8.
The Gracell team is scheduled to present on August 8th at 11:00 am ET and will host investor meetings at the conference on August 7-8.
About Gracell
Gracell Biotechnologies Inc. (“Gracell”) is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell and gene therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CARTTM technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com. Follow @GracellBio on LinkedIn.
CONTACT: Media contacts Marvin Tang marvin.tang@gracellbio.com Jessica Laub jessica.laub@westwicke.com Investor contacts Gracie Tong gracie.tong@gracellbio.com Stephanie Carrington stephanie.carrington@westwicke.com
NEW YORK, June 26, 2024 /PRNewswire/ -- The global veterinary software market size is estimated to…
MOUNT KISCO, N.Y., June 26, 2024 /PRNewswire/ -- The Mount Kisco Surgery Center LLC d/b/a…
REDWOOD CITY, Calif., June 26, 2024 /PRNewswire/ -- Ontinue, a leading provider of AI-powered managed extended…
ARCH-AI Can Help Radiology Sites Safely and Effectively Implement AI in Daily Practice RESTON, Va.,…
GRAND RAPIDS, Mich., June 26, 2024 /PRNewswire/ -- On June 24, 2024, Rep. Hillary Scholten (MI-03) joined…
BOSTON, June 26, 2024 /PRNewswire/ -- Two researchers at Shriners Children's Boston have created a revolutionary…